Eaton Vance Management Fibrogen Inc Put Options Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FGEN
# of Institutions
8Shares Held
3.98MCall Options Held
35KPut Options Held
0-
Black Rock Inc. New York, NY2.41MShares$20.9 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.37MShares$11.9 Million0.0% of portfolio
-
Intercontinental Wealth Advisors, LLC95.7KShares$831,1980.06% of portfolio
-
Cibc Private Wealth Group, LLC7.18KShares$62,3590.0% of portfolio
-
Cutler Group LP900Shares$7,8210.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $815M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...